deltatrials
Terminated PHASE4 NCT00590408

Efficacy and Safety of Coenzyme Q10 in the Treatment of Statin-Associated Myalgia

Sponsor: Creighton University

Conditions Statin-associated Myalgia
Interventions coenzyme Q10 matching placebo
Updated 6 times since 2017 Last updated: Nov 27, 2009 Started: Mar 31, 2006 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

Listed as NCT00590408, this PHASE4 trial focuses on Statin-associated Myalgia and remains terminated or withdrawn. Sponsored by Creighton University, it has been updated 6 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Creighton University
Data source: Creighton University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Omaha, United States